1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Enfermedades Infecciosas

Enfermedades Infecciosas

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Velasco M, Flores-Chávez MD, Llenas-García J, García Rodríguez M, García Vázquez E, López-Medrano F, Len O, Esperalba Esquerra J, Martínez Pérez Á, Díaz-Menéndez M, Moure García Z, Pérez Ayala A, Rodríguez Guardado A, Albasanz Puig A, Alguacil M, Álvarez-Martínez MJ, Arsuaga Vicente M, Belhassen Garcia M, Buitrago MJ, Calabuig E, de la Calle F, Dopico E, Fernández-Ruiz M, Gudiol C, Herrero-Martínez JM, Lozano Serrano AB, Martin O, Martín-Dávila P, de Miguel R, Muelas Fernández M, Navarro Beltrá M, Norman FF, Palacios Gutiérrez JJ, Pérez-Jacoiste A, Rodríguez-Sevilla G, Rodríguez Zúñiga D, Salvador F, Sánchez Montalvá A, Seral C, Vázquez González A, Wikman Jorgensen PE, Sulleiro Igual E.

    Executive summary of the consensus document of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC: GEPI, GeSIDA, GESITRA-IC, GEIRAS) on screening for imported infectious diseases in immunocompromised patients.

    Enfermedades Infecciosas Y Microbiologia Clinica (english Ed.) . 43(9): 611-615.

    [doi:10.1016/j.eimce.2025.07.005]

  • Díaz-García C, Serrano-Villar S, G García-Ruiz de Morales A, Güerri-Fernández R, Pérez-Somarriba J, Sánchez Palomino S, Suárez-García I, Hernández Gutiérrez C, Dalmau Juanola D, Moreno S, Moreno E, Martínez-Sanz J.

    Two or Three? Clinical and Proteomic Perspectives on Dolutegravir/Lamivudine Versus Bictegravir/Emtricitabine/Tenofovir Alafenamide as Initial HIV Treatment.

    Open forum infectious diseases . 12(11): .

    [doi:10.1093/ofid/ofaf626]

  • Behrens GMN, Assoumou L, De Wit S, MacDonald R, de Castro N, Rokx C, Middleditch H, Johnson M, Casado JL, Arribas JR, Blanco JR, Fletcher C, Eteve-Pitsaer C, Baldé A, Pozniak A, Martinez E.

    Morbidity and risk factors of COVID-19 in people with HIV-1 in Europe: A combined observational cohort and nested case-control study.

    HIV MEDICINE . 26(11): 1657-1672.

    [doi:10.1111/hiv.70094]

  • Gayoso Cantero D, Corbacho Loarte MD, Monge Maillo B.

    Diagnostic delay in Strongyloides stercoralis infections.

    MEDICINA CLINICA . 165(5): 107123-107123.

    [doi:10.1016/j.medcli.2025.107123]

  • Fortún J, Suárez M.

    Survival and quality-of-life in Mucormycosis.

    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases . 31(11): 1782-1784.

    [doi:10.1016/j.cmi.2025.07.034]

  • Maertens JA, Thompson GR 3rd, Spec A, Donovan FM, Hammond SP, Bruns AHW, Rahav G, Shoham S, Johnson R, Rijnders B, Schaenman J, Hoenigl M, Morrissey CO, Mehta SR, Heath CH, Koehler P, Paterson DL, Slavin MA, Fortún J, Nguyen MH, Patterson TF, Uspenskaya O, Van de Veerdonk FL, Verweij PE, Aoun M, Georgala A, Alexander BD, Chayakulkeeree M, Mehra V, Miceli MH, Sikka MK, Solé A, Walsh TJ, Aguado JM, Holland SM, Moussa M, Rautemaa-Richardson R, Bazaz R, Schwartz S, Walsh SR, Plate M, Yehudai-Ofir D, Brüggemann RJ, Cornely OA, Ostrosky-Zeichner L, Vazquez JA, White PL, Cornelissen K, Ross GG, Fitton L, Dane A, Zinzi D, Rex JH, Chen SC.

    Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b study.

    LANCET INFECTIOUS DISEASES . 25(11): 1177-1188.

    [doi:10.1016/S1473-3099(25)00224-5]

  • Casado JL, Vizcarra P, Martín-Hondarza A, Moreno A, Pérez-Elías MJ, Fernández-Chica C, Martín-Colmenarejo S, Vallejo A.

    Humoral and cellular immune responses in people living with HIV following successive COVID-19 vaccine booster doses.

    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases . 31(11): 1855-1864.

    [doi:10.1016/j.cmi.2025.06.007]

  • Fortún J.

    New evidence in the management of CMV infection: impact on prophylaxis and treatment.

    REVISTA ESPANOLA DE QUIMIOTERAPIA . 38 Suppl 1: 80-86.

    [doi:10.37201/req/s01.12.2025]

  • Jover F, Martínez-Sanz J, Antela A, López-Cavanillas M, Viguera-Moreno M, González-Rodríguez P, Domingo P.

    Is less truly more? - reassessing antiretroviral efficacy - a safety analysis for HIV patients switching from triple to double regimens with integrase inhibitors: A systematic review and meta-analysis.

    Medicine . 104(42): .

    [doi:10.1097/MD.0000000000045152]

  • Asensi-Díaz E, Barbero Del Olmo L, Urrutia P, Lario A, Gómez-G de la Pedrosa E, García-Ruiz de Morales AG, Martín-Dávila P, Fortún J.

    When Fungal Prophylaxis Fails: A Rare Case of Rhodotorula mucilaginosa Fungemia with Suspected Abdominal Origin.

    JOURNAL OF FUNGI . 11(10): .

    [doi:10.3390/jof11100723]

  • Halperin AV, Escudero R, García-Castillo M, Cardenas-Isasi MJ, Gioia F, Cobo J, Sánchez-Díaz AM, Cantón R.

    Randomized controlled diagnostic trial to assess dRAST time to result and its utility for antimicrobial stewardship recommendation in bacteremic patients.

    Microbiology spectrum . 13(10): .

    [doi:10.1128/spectrum.00288-25]

  • Suárez-García I, Moreno C, Alejos B, Izquierdo R, Pérez de la Cámara S, Pardo OB, Arenzana CB, Pérez-Elías MJ, López TP, Imaz A, Curran A, Hernando V, Jarrín I.

    Pregnancy in Women with HIV: Incidence and Outcomes over 19 Years in a Multi-Center Cohort in Spain.

    AIDS PATIENT CARE AND STDS . 39(10): 385-396.

    [doi:10.1177/10872914251387606]

  • Labiod N, Sánchez-Seco MP, Goikoetxea J, Zurita ND, Norman FF, Martínez MM, Alonso PA, Hernández-Betancor A, Sempere-Alcocer MA, Moure Z, Ocete MD, Vicente MR, de la Calle-Prieto F, Gallego M, Domingo LC, Galán JC, Camprubí-Ferrer D, Meilán C, Perez-Hernandez I, Cabezón I, Hernández FJ, Bernal E, Vázquez A.

    Case series of Oropouche fever among travellers returning from Cuba to Spain, 2024.

    Eurosurveillance . 30(41): .

    [doi:10.2807/1560-7917.ES.2025.30.41.2400719]

  • Rodriguez-Tierno S, Sáez de la Fuente J, Fuertes Pina L, Escudero-Sánchez R, Ruiz-Garbajosa P, Guijarro Martínez P, Gioia F, Pintor Recuenco MDR, Álvarez-Díaz A.

    Real-life experience with use of cefiderocol in non-critically ill patients in a tertiary care hospital.

    Enfermedades Infecciosas Y Microbiologia Clinica (english Ed.) . 43(8): 510-514.

    [doi:10.1016/j.eimce.2025.05.009]

  • Daneri L, Urbano A, Escudero-Sánchez R, Halperin AV, Moreno-Blanco A, Corbacho MD, Suárez-Carantoña C, Rodríguez-Jiménez C, Serrano-Villar S, Campo RD, Cobo J.

    Lyophilised fecal microbiota transfer in capsules for recurrent Clostridioides difficile infection.

    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS . 66(4): 107561-107561.

    [doi:10.1016/j.ijantimicag.2025.107561]

  • López-Olivencia M, de Pablo R, de Dios NP, García-Plaza S, Sáez-Noguero S, de la Fuente JS, Fortún J, Cuesta MCS.

    The adverse impact of cytomegalovirus infection on intensive care units outcomes in critically ill COVID-19 patients: a single-center prospective observational study.

    Infection . 53(5): 1801-1808.

    [doi:10.1007/s15010-025-02499-8]

  • Cadenas-Jiménez I, Badía-Tejero AM, López-Causapé C, Morosini MI, Portillo-Calderón I, Machado M, Larrosa N, Dávila PM, Palacios-Baena Z, Puig-Albasanz A, Tubau F, Oliver A, Sastre E, Martí S, Gudiol C.

    Molecular epidemiology and antimicrobial resistance profiles of Pseudomonas aeruginosa causing bloodstream infections in neutropenic cancer patients.

    FRONTIERS IN MICROBIOLOGY . 16: 1681506-1681506.

    [doi:10.3389/fmicb.2025.1681506]

  • Núñez LM, Benito AR, Bereciartua E, Morata L, Escudero-Sánchez R, Nadal JS, Gómez-Junyent J, Botrán AS, García AMA, Del Toro López MD, Ruiz-Cabrera D, Andrino JMR, Alidrous F, Torío-Salvador M, Verdejo MÁ, Velasco Arribas M.

    Real-World Use of Dalbavancin in Diabetic Foot Osteomyelitis: PEDDAL Study.

    Journal Of Clinical Medicine . 14(19): .

    [doi:10.3390/jcm14196705]